Bruker, headquartered in Billerica, Massachusetts, develops and distributes high-performance scientific instruments and solutions, employing 9,707 staff since its IPO in 2000. Key segments include BSI BioSpin, BSI CALID, BSI Nano, and BEST.
Thomas Bures bought 500 shares of BRKR on 10 March at $47.40 per share, worth a total of $24K. They now own 3,472 BRKR shares, or a 17% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
